Renaissance Technologies »

Aktis Oncology shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.1M 95k 32.23

More positions owned by Renaissance Technologies

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Intel Corporation (INTC)
United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl A (GOOGL)
Exelixis (EXEL)
Verisign (VRSN)
Kinross Gold Corp (KGC)
Crowdstrike Hldgs Cl A (CRWD)
Sterling Construction Company (STRL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Argan (AGX)
Netflix (NFLX)

View all positions for Renaissance Technologies

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
BlackRock
Wellington Management Company
Rtw Investments
T. Rowe Price Associates
Henderson Group
RA Capital Management
Jupiter Topco
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
TCG Crossover Management

View all funds holding Aktis Oncology